Form 8-K - Current report:
SEC Accession No. 0001104659-25-119680
Filing Date
2025-12-09
Accepted
2025-12-09 16:30:38
Documents
19
Period of Report
2025-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2533057d1_8k.htm   iXBRL 8-K 43977
2 EXHIBIT 4.1 tm2533057d1_ex4-1.htm EX-4.1 91237
3 EXHIBIT 4.2 tm2533057d1_ex4-2.htm EX-4.2 94481
4 EXHIBIT 4.3 tm2533057d1_ex4-3.htm EX-4.3 94416
5 EXHIBIT 10.1 tm2533057d1_ex10-1.htm EX-10.1 213770
6 EXHIBIT 10.2 tm2533057d1_ex10-2.htm EX-10.2 149657
7 EXHIBIT 10.3 tm2533057d1_ex10-3.htm EX-10.3 59607
8 EXHIBIT 99.1 tm2533057d1_ex99-1.htm EX-99.1 11356
  Complete submission text file 0001104659-25-119680.txt   1109698

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA apre-20251208.xsd EX-101.SCH 3005
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apre-20251208_lab.xml EX-101.LAB 34239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apre-20251208_pre.xml EX-101.PRE 22352
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2533057d1_8k_htm.xml XML 3567
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 251559489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)